Menu
Not yet recruiting NCT07208032

Pulsed Radiofrequency in Post Herptic Neuralgia

No phase Interventional Postherpetic Neuralgia (PHN)

For patients and families

In plain language

An automatic summary of structured registry data. It is an orientation aid, not a substitute for the official protocol or a physician assessment.

What is being studied
The protocol lists: Irregular Pulsed Radiofrequency (STP), regular pulsed Radiofrequency.
Who it may be relevant to
Registry conditions: Postherpetic Neuralgia (PHN). Basic parameters: No limits · All.
What needs checking
Age, condition and sex are only basic indicators. Prior treatment, laboratory values and other mandatory requirements appear in the eligibility criteria below.
Where it takes place
Egypt
Next step
Save the trial, show it to the treating physician, and confirm current recruitment with the study center. Costs, documents and travel →

Unsure about the terms? Read our patient guide →

Official title

Efficacy and Safety of STP Pulsed Radiofrequency Versus Regular Pulsed Radiofrequency for Treatment of Post Herpetic Neuralgia

Overview

Comparing between regular pulsed Radiofrequency and irregular pulsed Radiofrequency for treatment of postherpetic neuralgia

Interventions

  • Procedure Irregular Pulsed Radiofrequency (STP)
    Flouroscopic guided irregular pulsed Radiofrequency (STP) for dorsal root ganglion
  • Procedure regular pulsed Radiofrequency
    Fluoroscopic guided regular pulsed Radiofrequency for the dorsal root ganglion

Primary outcome measures

  • Pain level by Numerical Rating Scale [Time frame: One day , One week , One month ,Three months postprocedure.]

Eligibility criteria

Inclusion criteria

Patients with Herps Zoster neuralgia lasting more than one month Neck thoracic lumbar ganglion involvement Refractory to conventional therapy

Exclusion criteria

Infection ,tumour at the puncture site Severe cardiovascular or cerebrovascular disease Liver, kidney dysfunction Abnormal coagulation Uncontrolled DM Psychatric diseases Patient refusal

Criteria are shown verbatim from the registry (in English). Final eligibility is always assessed by the study center.

Healthy volunteers: No

Study design

Allocation
Randomized
Model
Parallel assignment
Masking
Triple blind
Primary purpose
Treatment

Study locations

Egypt · 2 centers
  • Medical research ethics committee — Sohag
  • Medical research ethics committee — Sohag

Identifiers

NCT: NCT07208032 · Soh-Med-25-2-7PD

Primary sources (government registries)

View this study on ClinicalTrials.gov ↗